Allogene Therapeutics, Inc. Common Stock (NASDAQ: ALLO) last traded at $1.43, down 2.40% on the session. The quote above updates while this page is open; the figures below are drawn from Allogene Therapeutics, Inc. Common Stock’s own filings and are restated only when a new one is published.
Allogene Therapeutics, Inc. Common Stock trades on NASDAQ under the ticker ALLO. Its market capitalisation is $492.32 million.
Valuation measures for Allogene Therapeutics, Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $492.32M |
|---|---|
| Enterprise value | $567.61M |
| Price / book | 1.13 |
| Beta | 1.90 |
Trailing-twelve-month figures tagged in Allogene Therapeutics, Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) |
|---|
| $0.00 |
| Net income (TTM) | -$165.49M |
|---|
| Return on equity | -37.94% |
|---|
| Cash | $38.63M |
|---|
Range and volume for ALLO over the past 52 weeks.
| 52-week high | $4.46 |
|---|---|
| 52-week low | $1.04 |
| Volume | 1.65M |
| Average volume | 5.65M |
| Previous close | $1.46 |
Dividend history for Allogene Therapeutics, Inc. Common Stock over the trailing twelve months.
| Dividend yield | 0.00% |
|---|---|
| Dividend per share (TTM) | $0.00 |
Invest a chosen dollar amount in Allogene Therapeutics, Inc. Common Stock with fractional shares.
Start investingCreate an account
Investing involves risk, including possible loss of principal. Nothing here is investment advice or a recommendation to buy or sell ALLO.
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.